Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer
Abstract Background Ovarian cancer is the leading cause of gynecologic cancer death in the United States despite effective first-line systemic chemotherapy. Cancer stem cells (CSCs) retain the ability to self-renew and proliferate and may be a means of harboring disease that evades standard treatmen...
Main Authors: | Elizabeth V. Connor, Caner Saygin, Chad Braley, Andrew C. Wiechert, Sheelarani Karunanithi, Katie Crean-Tate, Fadi W. Abdul-Karim, Chad M. Michener, Peter G. Rose, Justin D. Lathia, Ofer Reizes |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13048-019-0590-5 |
Similar Items
-
CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule
by: Chloé Sauzay, et al.
Published: (2019-04-01) -
Expression und Regulation von CD90 (Thy-1) auf makrovaskulären Endothelzellen
by: Uptaite, Migle
Published: (2013) -
Evaluierung eines Modellsystems unter Nutzung der
Thy–1/Thy–1 – Ligand Interaktion zur Testung
anti – inflammatorischer Substanzen
by: Molkenthin, geb. Schubert, Claudia
Published: (2016) -
Thy-1 (CD90) Signaling Preferentially Promotes RORγt Expression and a Th17 Response
by: Suzanne Furlong, et al.
Published: (2018-11-01) -
Thy-1/CD90 a Bidirectional and Lateral Signaling Scaffold
by: Lisette Leyton, et al.
Published: (2019-07-01)